Web Analytics

3 Latest Announced Rounds

  • $5,300,000
    Seed

    4 Investors

    Software Development
    Oct 24th, 2025
  • $20,000,000
    Series A

    1 Investors

    Financial Services
    Oct 24th, 2025
  • $38,500,000
    Seed

    4 Investors

    Technology, Information and Internet
    Oct 24th, 2025
$822.16M Raised in 50 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Carmot Therapeutics, Inc.

start up
United States - Berkeley
  • 26/07/2022
  • Series D
  • $160,000,000

Carmot Therapeutics, Inc. is a clinical-stage company dedicated to the discovery and development of innovative medicines. Carmot applies a transformative, patented drug discovery approach, Chemotype Evolution to explore novel frontiers of chemistry and biology. Using Chemotype Evolution, Carmot has developed a portfolio of drug candidates in metabolic disease and oncology.


Related People

Stig HansenCo Founder

Stig Hansen United States - Berkeley, California

NA